Invention Grant
- Patent Title: Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers
-
Application No.: US17245918Application Date: 2021-04-30
-
Publication No.: US11786583B2Publication Date: 2023-10-17
- Inventor: Toni Weinschenk , Andrea Mahr , Jens Fritsche , Phillip Mueller , Anita Wiebe , Sarah Kutscher
- Applicant: IMMATICS BIOTECHNOLOGIES GMBH
- Applicant Address: DE Tuebingen
- Assignee: IMMATICS BIOTECHNOLOGIES GMBH
- Current Assignee: IMMATICS BIOTECHNOLOGIES GMBH
- Current Assignee Address: DE Tuebingen
- Agency: McBee Moore & Vanik IP, LLC
- Priority: GB 23016 2014.12.23 GB 01017 2015.01.21
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/04 ; C07K7/06 ; C07K7/00 ; A61K35/17 ; C07K16/18 ; G01N33/68 ; C07K14/435 ; C07K7/08 ; A61K51/10 ; A61K35/12 ; C12N5/0783 ; C12N15/115 ; C07K14/725 ; C07K14/74
Abstract:
A peptide consists of the amino acid sequence KLSPTVVGL (SEQ ID NO: 6) in the form of a pharmaceutically acceptable salt, in which the peptide has the ability to bind to an MHC class-I molecule and, when bound to MHC, is capable of being recognized by CD8 T cells. A composition contains a peptide consisting of the amino acid sequence KLSPTVVGL (SEQ ID NO: 6), an adjuvant, and a pharmaceutically acceptable carrier.
Public/Granted literature
Information query
